NDC Code(s) : 0074-6633-22, 0074-6633-30
Packager : AbbVie Inc.

Category : HUMAN PRESCRIPTION DRUG LABEL

DEA Schedule : none

Marketing Status : New Drug Application

INGREDIENTS AND APPEARANCE

NorvirRitonavir CAPSULE
Product Information
Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:0074-6633
Route of Administration ORAL DEA Schedule
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
RITONAVIR(UNII: O3J8G9O825)
(RITONAVIR - UNII:O3J8G9O825) 		RITONAVIR100 mg
Inactive Ingredients
Ingredient Name Strength
BUTYLATED HYDROXYTOLUENE(UNII: 1P9D0Z171K)
ALCOHOL(UNII: 3K9958V90M)
GELATIN(UNII: 2G86QN327L)
OLEIC ACID(UNII: 2UMI9U37CP)
POLYOXYL 35 CASTOR OIL(UNII: 6D4M1DAL6O)
TITANIUM DIOXIDE(UNII: 15FIX9V2JP)
FERRIC OXIDE RED(UNII: 1K09F3G675)
Product Characteristics
Color WHITE Score no score
Shape OVAL Size 22 mm
Flavor Imprint Code 100;DS
Contains
Packaging
# Item Code Package Description Marketing Start Date Marketing End Date
1NDC:0074-6633-22120 in 1 BOTTLE Type 0: Not a Combination Product05/06/2010
2NDC:0074-6633-3030 in 1 BOTTLE Type 0: Not a Combination Product06/05/2010
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
NDA NDA020945 05/06/2010

PRINCIPAL DISPLAY PANEL

NDC 0074–6633–30

Norvir®

Ritonavir Capsules Soft Gelatin 100 mg 30 Capsules

ALERT: Find out about medicines that should NOT be taken with NORVIR

Note to Pharmacist: Do not cover ALERT box with pharmacy label.

Package insert is provided with tear-off patient information.

Rx only abbvie

norvir capsules 100mg 30ct bottle